documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

6 rows where docket_id = "FDA-2003-E-0329" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_month, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 2

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2003-E-0329-0006 FDA Patent Extension for Strattera (atomoxetine hydrochloride), 5,658,590 FDA-2003-E-0329 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2004-06-28T04:00:00Z 2004 6     2025-10-28T17:55:06Z   0 0 0900006480495956
FDA-2003-E-0329-0005 FDA Patent Extension for Strattera (atomoxetine hydrochloride), 5,658,590 FDA-2003-E-0329 Determination of Regulatory Review Period for Purposes of Patent Extension; STRATTERA Notice General Notice 2003-12-05T05:00:00Z 2003 12 2003-12-03T05:00:00Z   2025-10-28T17:50:57Z 03-30028 0 0 0900006480495953
FDA-2003-E-0329-0004 FDA Patent Extension for Strattera (atomoxetine hydrochloride), 5,658,590 FDA-2003-E-0329 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2003-11-12T05:00:00Z 2003 11     2025-10-28T17:45:49Z   0 0 0900006480495951
FDA-2003-E-0329-0003 FDA Patent Extension for Strattera (atomoxetine hydrochloride), 5,658,590 FDA-2003-E-0329 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2003-10-06T04:00:00Z 2003 10     2025-10-28T17:43:24Z   0 0 090000648049594f
FDA-2003-E-0329-0002 FDA Patent Extension for Strattera (atomoxetine hydrochloride), 5,658,590 FDA-2003-E-0329 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2003-07-29T04:00:00Z 2003 7     2025-10-28T17:39:35Z   0 0 090000648049594d
FDA-2003-E-0329-0001 FDA Patent Extension for Strattera (atomoxetine hydrochloride), 5,658,590 FDA-2003-E-0329 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2003-06-09T04:00:00Z 2003 6     2025-10-28T17:37:02Z   0 0 09000064804958fb

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;